header-4.jpg
About Us

Margot Lehman

Margot Lehman

Positions

  • Senior Staff Specialist, Radiation Oncology, Princess Alexandra Hospital
  • Member, Multidisciplinary Team Clinic for Advanced Prostate Cancer, PAH

Contact Details

Phone
+61 7 3176 6586

Related websites and profiles

Qualifications

  • Graduate Diploma Public Health, Biostatistics and Epidemiology, University of Queensland, Australia, 2004
  • FRANZCR (Fellow of the Royal Australian & New Zealand College), Royal Australian & New Zealand College of Radiologists, Australia, 1998
  • MBBS (Hons), University of Queensland, Australia, 1986

Biography

On completion of her MBBS (Hons) at the University of Queensland, Dr Margot Lehman commenced her internship at Royal Brisbane Hospital where she continued on to become House Officer, and finally Anaesthetic Registrar. Dr Lehman left Royal Brisbane Hospital in 1993 to take up a Radiation Oncology Registrar position at the Prince of Wales Hospital in Sydney.

From June 1998 to June 1999, Dr Lehman worked as a Locum Staff Specialist in Radiation Oncology at the Westmead Hospital in Sydney. The following 12 months saw her working as a Fellow of Radiation Oncology at the University of Toronto in Canada.

On returning to Australia in mid-2000, Dr Lehman took up the role of Staff Specialist in Radiation Oncology at Geelong Hospital. She remained in this role for two years before commencing her current role as Staff Specialist Radiation Oncology at the Princess Alexandra Hospital in April 2002.

Dr Lehman collaborates closely with researchers from the APCRC-Q and is an integral part of the Multidisciplinary Team Clinic.

Awards and grants

Awards

    2000 Chairman's Award for Excellence in Clinical Research, University of Toronto
    1997 Finalist - Tow Research Awards, The Prince of Wales Hospital

    Grants

    2012-2015 Cancer Australia's Priority-Driven Collaborative Cancer Research Scheme A Randomised Phase III trial of high dose palliative radiotherapy versus concurrent chemotherapy and high dose palliative radiotherapy in patients with good performance status, locally advanced/small volume metastatic NSCLC not suitable for radical chemo-radiotherapy M Lehman, Michael M, D Ball, M King, R Fisher
    2012 Princess Alexandra Hospital Cancer Collaborative Group Centres for Health Research Grant Circulating tumour cells and myeloid-derived suppressor cells in patients with locally advanced or metastatic non-small cell lung cancer M Lehman, J Upham, Fanning M, Jovanovic, L

    Research interests

    Circulating tumour cells in high risk prostate cancer

    Current research projects

        1. Patient’s preferences for Prophylactic Cranial Irradiation following completion of definitive therapy for Stage III NSCLC:  A Discrete Choice Experiment.  Lehman M, Gorayski P, Jackson J, Watson S.
        2. A retrospective review of a single institution’s experience with Carboplatin/Taxol given concurrently with radiation therapy in the definitive management of Stage III NSCLC.  Horword K, Pinkham M, Lehman M.
        3. A Pilot study detecting the incidence of circulating tumour cells in men with high risk prostate cancer.  Lehman M, Jovanovic L

        Top publications

        • Daly T, Hickey BE, Lehman M, Francis DP, See AM. Adjuvant radiotherapy following radical prostatectomy for prostate cancer. Cochrane Database Sys Review 2011 Dec7; 12:CD00723
        • Burmeister BH, Michael M, Burmeister E, Cox S, Lehman M, Wirth A et al.  A randomised phase II trial of two regimens of moderate dose chemoradiation therapy for patients with non-small cell lung cancer not suitable for curative therapy: Trans Tasman Radiation Oncology Study TROG 03.07. J Thorac Oncol 2011 Dec; 6(12):2076-82.
        • Brown S, Lehman M, Ferrari-Anderson J, Glyde A, Burmeister E, Nicol D.  Assessment of prostatic fiducial marker introduction:  patient morbidity, staff satisfaction and improved treatment field placement.  J Med Imaging Radiat Oncol 2011 Aug; 55(4): 417-24.
        • Sidhom MA, Kneebone AB, Lehman M et al. Post-prostatectomy radiation therapy:  Consensus guidelines of the Australian and New Zealand Radiation Oncology Genito-Urinary Group. Radiotherapy and Oncology 2008; 88 : 10-19.
        • Haines T, Sinnamon P, Lehman M, Wetzig N, Walpole E, Pratt T et al:  Multi-modal exercise improves Quality of Life of women being treated for breast cancer, but at what cost?  Randomised Trial with Economic Evaluation.  Breast Cancer Research and Treatment. 2010; 124 (1): 163-175.

        Professional memberships and associations

        Current Member of the Trans-Tasman Radiation Oncology Group
        Current Member of the Executive of the Faculty of Radiation Oncology Genito-urinary Interest Group (FROGG)
        Current Member of the Australian Medical Association
        Current Member of the Australian Lung Cancer Trials Gorup
        Current Member of the International Association for the Study of Lung Cancer
        Current Member of ANZUP
        Current Chair, Training Resource Executive, the Royal Australian and New Zealand College of Radiologist Faculty of Radiation Oncology
        Current Member RANZCR FRO Education Board
        Current Examiner for Part II examinations FRANZCR FRO
        Current Member RANZCR FRO Curriculum Review Committee
        Current Director of Training, Metropolitan South Radiation Oncology
        Current Member Training Network Committee Metropolitan Brisbane
        Current Member Queensland Cancer Control Safety and Quality Partnership Quality Assurance Committee - Breast Cancer Subcommittee

         

            Upcoming Events

            Apr 13, 2019 - Apr 16, 2019 USANZ 2019
            Brisbane Convention and Exhibition Centre